These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10096336)

  • 1. Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo.
    Blüml S; Tan J; Harris K; Adatia N; Karme A; Sproull T; Ross B
    J Comput Assist Tomogr; 1999; 23(2):272-5. PubMed ID: 10096336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.
    Fukuzako H
    World J Biol Psychiatry; 2001 Apr; 2(2):70-82. PubMed ID: 12587188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phosphorus 31 magnetic resonance spectroscopy in schizophrenia research. Pathophysiology of cerebral metabolism of high-energy phosphate and membrane phospholipids].
    Riehemann S; Volz HP; Smesny S; Hübner G; Wenda B; Rössger G; Sauer H
    Nervenarzt; 2000 May; 71(5):354-63. PubMed ID: 10846710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton-decoupled 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy.
    Bluml S; Zuckerman E; Tan J; Ross BD
    J Neurochem; 1998 Oct; 71(4):1564-76. PubMed ID: 9751190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].
    Wobrock T; Scherk H; Falkai P
    Radiologe; 2005 Feb; 45(2):124-30, 132-6. PubMed ID: 15645203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance spectroscopy in schizophrenia].
    Delamillieure P; Constans JM; Fernandez J; Dollfus S
    Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest.
    Shirayama Y; Yano T; Takahashi K; Takahashi S; Ogino T
    Eur J Neurosci; 2004 Aug; 20(3):749-56. PubMed ID: 15255985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases.
    Hoang TQ; Bluml S; Dubowitz DJ; Moats R; Kopyov O; Jacques D; Ross BD
    Neurology; 1998 Apr; 50(4):1033-40. PubMed ID: 9566391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies.
    Shioiri T; Hamakawa H; Kato T; Fujii K; Murashita J; Inubushi T; Someya T
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(4):169-74. PubMed ID: 11009069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of olanzapine on 31P MRS metabolic markers in schizophrenia.
    Nenadic I; Dietzek M; Langbein K; Rzanny R; Gussew A; Reichenbach JR; Sauer H; Smesny S
    Hum Psychopharmacol; 2013 Jan; 28(1):91-3. PubMed ID: 23225665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy changes after antipsychotic treatment.
    Szulc A; Galinska-Skok B; Waszkiewicz N; Bibulowicz D; Konarzewska B; Tarasow E
    Curr Med Chem; 2013; 20(3):414-27. PubMed ID: 23157634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.
    Komoroski RA; Pearce JM; Mrak RE
    Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Br J Psychiatry; 2004 May; 184():409-15. PubMed ID: 15123504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study].
    Szulc A; Galińiska B; Tarasów E; Dzienis W; Kubas B; Konarzewska B; Waszkiewicz N; Popławska R
    Psychiatr Pol; 2010; 44(3):415-26. PubMed ID: 20672520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study.
    Gangadhar BN; Jayakumar PN; Subbakrishna DK; Janakiramaiah N; Keshavan MS
    Am J Psychiatry; 2004 Jul; 161(7):1304-6. PubMed ID: 15229069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.